Hypercortisolism: Difference between revisions

 
(One intermediate revision by the same user not shown)
Line 87: Line 87:
#* Stone formers with cushingoid features also should receive a hypercortisolemia evaluation
#* Stone formers with cushingoid features also should receive a hypercortisolemia evaluation


=== Laboratory ===
=== Labs ===


* '''Most frequently performed laboratory tests (3):'''
* '''<span style="color:#ff0000">Most frequently performed laboratory tests (3):'''
*# '''Overnight low-dose dexamethasone suppression test (LD-DST)''' (sensitivity: 85-90, specificity: 95-99)
*# '''<span style="color:#ff0000">Overnight low-dose dexamethasone suppression test (LD-DST)</span>''' (sensitivity: 85-90, specificity: 95-99)
*# '''Late-night salivary cortisol''' (sensitivity: 92-100, specificity: 93-100§)
*# '''<span style="color:#ff0000">Late-night salivary cortisol</span>''' (sensitivity: 92-100, specificity: 93-100§)
*# '''24-hour urinary free cortisol''' (sensitivity: 80-98 specificity: 45-98)
*# '''<span style="color:#ff0000">24-hour urinary free cortisol</span>''' (sensitivity: 80-98 specificity: 45-98)
** '''2011 CUA Guidelines on Incidental Adrenal Mass recommend LD-DST'''
** '''<span style="color:#ff0000">2011 CUA Guidelines on Incidental Adrenal Mass recommend LD-DST</span>'''
* Second-line tests:
* Second-line tests:
** 2-day low-dose dexamethasone suppression test
** 2-day low-dose dexamethasone suppression test